Senate Finance Chair Ron Wyden (D-OR) (Francis Chung/E&E News/POLITICO via AP Images)
Senate Finance chair goes after Amgen again on US taxes, asking for payment specifics
Senate Finance Chair Ron Wyden is asking Amgen again for more information on its financials as he continues to dig into the way pharma companies use subsidiaries in low- or zero-tax countries to lower their bills.
The Democrat senator from Oregon said today that he sent Amgen a final request for “voluntary compliance” to provide specific information on Amgen’s financials. The letter, addressed to Amgen CEO Robert Bradway, asked him to explain how Amgen paid a lower tax rate than the standard corporate tax rate in the US of 21%.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters